BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/22/2022 8:57:44 AM | Browse: 629 | Download: 1409
 |
Received |
|
2021-12-17 22:22 |
|
Peer-Review Started |
|
2021-12-17 22:24 |
|
First Decision by Editorial Office Director |
|
2022-01-25 08:50 |
|
Return for Revision |
|
2022-01-25 08:50 |
|
Revised |
|
2022-02-08 01:11 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-03-07 06:06 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-03-17 04:17 |
|
Articles in Press |
|
2022-03-17 04:17 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-03-17 07:49 |
|
Publish the Manuscript Online |
|
2022-03-22 08:57 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Retrospective Study |
| Article Title |
Risk profiles and outcomes of patients receiving antibacterial cardiovascular implantable electronic device envelopes: A retrospective analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
David A Woodard, Grace Kim and Kent R Nilsson |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Aziyo Biologics, Inc. |
|
|
| Corresponding Author |
David A Woodard, MD, Doctor, Doctor, Department of Cardiology, Piedmont Heart Institute, Piedmont Athens Regional Medical Center
242 King Ave Suite 210, Athens, GA 30606, United States. davidwoodard92464@gmail.com |
| Key Words |
Cardiovascular implantable electronic device envelope; Defibrillator; Extracellular matrix; Implantable cardioverter-defibrillator; Infection; Pacemaker |
| Core Tip |
This retrospective study was performed to determine risk profiles and clinical outcomes of patients who underwent cardiovascular implantable electronic device (CIED) procedures with a biologic or non-biologic antibacterial envelope, or no envelope. A total of 248 patient records were reviewed containing 89 biologic, 102 non-biologic, and 57 no envelope patients. Pre-procedurally, patients who received any envelope (biologic or non-biologic) were at higher infection risk than patients who received no envelope. Biologic envelopes tended to be used more often in higher risk patients than non-biologic envelopes. The rate of CIED pocket infection was low and equivalent between the two envelopes. |
| Publish Date |
2022-03-22 08:57 |
| Citation |
Woodard DA, Kim G, Nilsson KR. Risk profiles and outcomes of patients receiving antibacterial cardiovascular implantable electronic device envelopes: A retrospective analysis. World J Cardiol 2022; 14(3): 177-186 |
| URL |
https://www.wjgnet.com/1949-8462/full/v14/i3/177.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v14.i3.177 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
